Study: Pfizer-BioNTech vaccine effective against coronavirus variant detected in India
Two weeks after the second dose, the Pfizer-BioNTech COVID-19 vaccine was 88 percent effective against symptomatic disease from a coronavirus variant first identified in India that is spreading in the United Kingdom and could soon become the dominant strain there, a study by Public Health England found.
The results, released Saturday, are similar to the 93 percent effectiveness against another variant first identified in the U.K. last year, suggesting the vaccine still offers significant protection despite fears that the variant discovered in India, which is believed to be more contagious, would be resistant to vaccines. The research was conducted between April 5 and May 16.
The study also found that the vaccine developed by the University of Oxford and AstraZeneca, which has not been approved for emergency use by the Food and Drug Administration in the United States, was 60 percent effective against the variant first detected in India after two doses, similar to the 66 percent mark against the variant first detected in the U.K.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Although the study instills confidence in the vaccines, it also indicates that getting the full dosing regimen is crucial when it comes to maximizing protection against the virus. Both vaccines were 33 percent effective against symptomatic disease from the variant detected in India three weeks after the first dose, compared to 50 percent against the variant discovered in the U.K. Read more at Axios and The Guardian.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
A Man on the Inside: Netflix comedy leaves you with a 'warm fuzzy feeling'
The Week Recommends Charming series has a 'tenderness' that will 'sneak up' on you
By The Week UK Published
-
Bread & Roses: an 'extraordinarily courageous' documentary
The Week Recommends Sahra Mani's 'powerful' film examines the lives of three Afghan women under the Taliban
By The Week UK Published
-
V13: a 'marvelous and terrifying' account of the Bataclan terror trials
The Week Recommends Emmanuel Carrère's work is 'absolutely gripping'
By The Week UK Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published